A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy
Clinical trial NCT05287386 · UNKNOWN
Trial details
- NCT number
- NCT05287386
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2024-01-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.